Teleflex Incorporated Teleflex Incorporated

Teleflex Incorporated

TFX

Rank in Stocks #3219
Teleflex Incorporated is a global medical technology company dedicated to... Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Share Price
$130.16
Last synced: 2026-10-16
Market Cap
$5.52B
Change (1 day)
1.43%
Change (1 year)
1.58%
Country
US
Trade Teleflex Incorporated (TFX)

Category

Healthcare
Operating Margin for Teleflex Incorporated (TFX)
Operating Margin as of October 2026 TTM: 3.35%
According to Teleflex Incorporated latest financial reports and stock price the company's current Operating Margin (TTM) is 3.35%. At the end of 2023 the company had an Operating Margin of 17.02%.
Operating Margin history for Teleflex Incorporated from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 3.35% -32.46%
2024 4.96% -70.86%
2023 17.02% -4.92%
2022 17.90% -19.95%
2021 22.36% 34.13%
2020 16.67% 1.28%
2019 16.46% 25.27%
2018 13.14% -24.27%
2017 17.35% 1.46%
2016 17.10% -2.06%
2015 17.46% 12.79%
2014 15.48% 12.58%
2013 13.75% -318.95%
2012 -6.28% -141.18%
2011 15.25% 0.39%
2010 15.19% 6.45%
2009 14.27% 1.64%
2008 14.04% 40.96%
2007 9.96% 3.53%
2006 9.62% -2.53%
2005 9.87% 75.94%
2004 5.61% -93.92%
2003 92.21% 827.67%
2002 9.94% 0.61%
2001 9.88% -2.56%
2000 10.14% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
31.28% -90.66%
US
12.36% -96.31%
FR
0.00% -
JP
9.83% -97.07%
US
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.